BRRN vs VEEV vs WAY Stock Comparison

Bryn, Veeva Systems and Waystar Holding Prices as of Oct 22, 2026 Peers: Industry group
1 more company in this comparison (SDGR) Create a free account to keep reading and compare up to 10 companies.
BRRN Bryn Inc.
$2,100.00 +6,999,900.0% 1M +4,199,900.0% 1Y
Market cap
$945.00B
P/E
–
Revenue (TTM)
—
Div. yield
–
Healthcare IT Technology
3 wins
VEEV Veeva Systems Inc
$322.91 +19.2% 1M +10.8% 1Y
Market cap
$51.67B
P/E
50.9x
Revenue (TTM)
$3.46B
Div. yield
–
Healthcare IT Technology
3 wins
WAY Waystar Holding Corp.
$28.85 +16.5% 1M -24.1% 1Y
Market cap
$5.50B
P/E
40.8x
Revenue (TTM)
$1.21B
Div. yield
–
Healthcare IT Technology
3 wins

Head to Head

9 decided of 12

Bryn leads on 3 of the 12 questions below (Bryn 3, Waystar Holding 3, Veeva Systems 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBRRNVEEVWAYLeader
Larger companyMarket capitalisation $945.00B $51.67B $5.50B BRRN
Cheaper on earningsLower P/E, profitable companies only -4,205,121x 50.9x 40.8x WAY
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 36.0x 16.6x WAY
Faster revenue growthRevenue growth, trailing twelve months — +16.5% +19.2% WAY
More profitableNet margin, trailing twelve months — 29.3% 11.2% VEEV
Better return on capitalReturn on invested capital — — 3.5% –
Less leveragedLower net debt / EBITDA — — 2.9x –
Higher dividend yieldTrailing dividend yield — 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +4,199,900.0% +10.8% -24.1% BRRN
Better 5-year returnAnnualised price return, 5 years +595.4%/yr +0.1%/yr — BRRN
Less volatileAnnualised volatility, 1 year 1,144.4% 42.8% 54.6% VEEV
Higher overall scoreMean of the five percentile scores vs peers 14/100 68/100 58/100 VEEV

Percentile Scorecard

BRRNVEEVWAY

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBRRNVEEVWAY
Valuation 39 #55 of 90 35 #59 of 90 71 #27 of 90
Growth 1 #81 of 82 74 #22 of 82 68 #27 of 82
Profitability – 87 #11 of 77 74 #21 of 77
Financial Health 0 #96 of 96 95 #6 of 96 55 #44 of 96
Shareholder Returns – 49 #28 of 54 23 #42 of 54
Overall 14 68 58
  • BRRN ranked among 99 companies in Vertical Software
  • VEEV ranked among 99 companies in Vertical Software
  • WAY ranked among 99 companies in Vertical Software

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBRRNVEEVWAYSPY
1 month +6,999,900.0%+19.2%+16.5% -1.0%
3 months +2,624,900.0%+73.3%+28.2% +2.9%
6 months +3,499,900.0%+100.4%+13.5% +6.4%
Year to date +3,499,900.0%+44.7%-11.9% +11.4%
1 year +4,199,900.0%+10.8%-24.1% +13.1%
3 years +20,999,900.0%+63.8%— +79.4%
3 years, per year +5,860.6%+17.9%— +21.5%
5 years +1,615,284.6%+0.7%— +67.7%
5 years, per year +595.4%+0.1%— +10.9%
10 years +262,400.0%+732.0%— +255.2%
10 years, per year +119.8%+23.6%— +13.5%

Risk

MeasureBRRNVEEVWAYSPY
Volatility, 1Y 1,144.4%42.8%54.6% 12.7%
Downside volatility, 1Y 1,376.0%40.4%58.1% 12.7%
Beta vs S&P 500, 1Y -1.960.580.55 1.00
Return / volatility, 1Y 3,669.860.25-0.44 1.03
Max drawdown, 5Y -97.3%-53.2%-61.8% -25.4%
From 52-week high 0.0%0.0%-27.2% -2.5%
52-week high $2,100.00$322.91$39.62 $779.14
52-week low $0.02$151.43$17.31 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBRRNVEEVWAY
P/E now vs peer median -4,205,121xmedian 42.7x 51.7xmedian 42.7x 41.1xmedian 42.7x
P/S now vs peer median —median 2.7x 15.1xmedian 2.7x 4.6xmedian 2.7x
EV/EBITDA now vs peer median —median 19.0x 41.2xmedian 19.0x 15.7xmedian 19.0x
P/FCF now vs peer median -5,832,037xmedian 19.6x 31.4xmedian 19.6x 22.5xmedian 19.6x
P/B now vs peer median -4,626,456xmedian 1.8x 7.0xmedian 1.8x 1.4xmedian 1.8x
PEG now vs peer median —median 1.75 2.25median 1.75 —median 1.75

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBRRNVEEVWAY
Revenue – $3.46B $1.21B
Gross profit – $2.59B $833.24M
Operating income -$224.73K $1.03B $275.76M
Net income -$224.73K $1.01B $134.79M
Free cash flow -$162.04K $1.67B $246.26M
R&D – $821.92M $67.01M
EPS (diluted) – $6.15 $0.69
Cash & equivalents – $1.81B $12.65M
Total debt $413.56K – $5.39B
Shares (diluted) – 165.06M 194.51M
Enterprise value $945.00B $23.91B $4.65B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBRRNVEEVWAY
P/E -4,205,121x 51.7x 41.1x
P/FCF -5,832,037x 31.4x 22.5x
P/Operating cash flow -5,832,037x 31.4x 18.9x
P/S – 15.1x 4.6x
P/B -4,626,456x 7.0x 1.4x
P/Tangible book -4,626,456x 7.1x 2.0x
EV/EBITDA – 41.2x 15.7x
EV/EBIT -4,205,122x 43.5x 24.7x
EV/Revenue – 13.0x 5.6x
EV/FCF -5,832,038x 27.0x 27.7x
EV/Operating cash flow -5,832,038x 27.0x 23.3x
PEG (3Y EPS CAGR) – 2.25 –

Growth

14 metrics
MetricBRRNVEEVWAY
Revenue growth (1Y) – 16.5% 19.2%
Revenue CAGR (3Y) – 15.7% –
Gross profit growth (1Y) – 15.5% 22.4%
Gross profit CAGR (3Y) – 18.0% –
Operating income growth (1Y) -241.7% 29.5% 31.1%
Operating income CAGR (3Y) -119.3% 37.8% –
Net income growth (1Y) -241.7% 25.3% 56.8%
Net income CAGR (3Y) -27.9% 23.4% –
EPS growth (1Y) – 27.3% 46.4%
EPS CAGR (3Y) – 22.9% –
Operating cash flow growth (1Y) -102.4% 23.4% -3.8%
Operating cash flow CAGR (3Y) -104.6% 19.5% –
Free cash flow growth (1Y) -102.4% 23.4% -11.6%
Free cash flow CAGR (3Y) -104.6% 19.5% –

Profitability

14 metrics
MetricBRRNVEEVWAY
Gross margin – 75.0% 69.1%
EBITDA margin – 31.6% 36.1%
Operating margin – 29.9% 22.9%
Pretax margin – 38.4% 16.2%
Net margin – 29.3% 11.2%
FCF margin – 48.2% 20.4%
Operating cash flow margin – 48.2% 24.3%
Return on equity – 13.8% 3.4%
Return on assets -10,997% 11.2% 2.3%
Return on invested capital – – 3.5%
Return on capital employed – 13.5% 4.9%
Asset turnover – 0.4x 0.2x
Cash conversion (OCF / net income) 0.7x 1.6x 2.2x
Stock comp / revenue – 14.3% 4.1%

Financial Health

11 metrics
MetricBRRNVEEVWAY
Debt / assets 7,283% – 25.0%
Debt / equity -0.7x – 0.4x
Net debt / EBITDA – – 2.9x
Debt / FCF -0.9x – 6.0x
Liabilities / assets 10,800% 18.0% 32.1%
Equity / assets -10,700% 82.0% 67.9%
Interest coverage – – 3.4x
Current ratio 0.0x 5.5x 1.8x
Quick ratio – 5.4x 1.6x
Cash ratio – 5.0x 0.8x
Altman Z-score – 21.63 2.16

Shareholder Returns

7 metrics
MetricBRRNVEEVWAY
Dividend yield – – –
Net buyback yield – 0.7% -0.4%
Shareholder yield – 0.7% -0.4%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBRRNVEEVWAY
Forward P/E – 36.0xFY2026 16.6xFY2026
EPS, next fiscal year – $8.97FY2026 $1.74FY2026
EPS growth, next FY – +10.7%FY2026 +22.5%FY2026
EPS growth, the year after – +16.8% +10.3%
Revenue, next fiscal year – $3.60BFY2026 $1.21BFY2026
Revenue growth, next FY – +12.5%FY2026 +10.0%FY2026
Revenue growth, the year after – +17.3% +12.9%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBRRNVEEVWAY
Held by institutions – 88.8% 100.0%
Institutions holding – 1,056 302
Change in shares held, QoQ – +5.7% +3.3%
Institutions buying – 586 187
Institutions selling – 358 88
Buyers to sellers – 1.64 2.13

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BRRNVEEVWAY
BRRN 1.00 0.04 -0.06
VEEV 0.04 1.00 0.50
WAY -0.06 0.50 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BRRN, VEEV and WAY?

Bryn (BRRN) is the largest by market capitalisation: Bryn (BRRN) $945.00B, Veeva Systems (VEEV) $51.67B, Waystar Holding (WAY) $5.50B.

Which stock is cheaper, BRRN, VEEV and WAY?

Waystar Holding (WAY) trades on the lowest price-to-earnings ratio (Bryn (BRRN) -4,205,121x, Veeva Systems (VEEV) 50.9x, Waystar Holding (WAY) 40.8x). On next year's consensus earnings, Waystar Holding (WAY) is cheapest (Veeva Systems (VEEV) 36.0x, Waystar Holding (WAY) 16.6x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Waystar Holding (WAY) grew revenue fastest over the trailing twelve months: Veeva Systems (VEEV) +16.5%, Waystar Holding (WAY) +19.2%.

Which company is more profitable?

Veeva Systems (VEEV) has the highest net margin (Veeva Systems (VEEV) 29.3%, Waystar Holding (WAY) 11.2%).

Which stock has performed better?

Over the past year Bryn (BRRN) returned the most: Bryn (BRRN) +4,199,900.0%, Veeva Systems (VEEV) +10.8%, Waystar Holding (WAY) -24.1%. Over five years, Bryn (BRRN) compounded fastest (Bryn (BRRN) +595.4%/yr, Veeva Systems (VEEV) +0.1%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Veeva Systems (VEEV) has been the steadiest (Bryn (BRRN) 1,144.4%, Veeva Systems (VEEV) 42.8%, Waystar Holding (WAY) 54.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BRRN, VEEV and WAY?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Bryn (BRRN) leads on 3. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.